N-α-Fmoc-L-glutamine

N-α-Fmoc-L-glutamine is the L-glutamine amino acid bearing an N-(9H-fluoren-9-ylmethoxycarbonyl) (Fmoc) protecting group on the α-amino functionality, while retaining the side-chain amide of glutamine as a polar, hydrogen-bonding functional group. The molecule contains a stereogenic center at the α-carbon with L-configuration, a carboxylic acid that can be activated for coupling, and a protected carbamate that is stable to many peptide-synthesis conditions but can be removed under base to expose the free amine. The side-chain amide participates in intermolecular recognition and can be carried through peptide assembly or selectively transformed during downstream derivatization. As a protected amino acid building block, N-α-Fmoc-L-glutamine functions as a chiral intermediate for peptide construction, chemical biology probes, and process-compatible fine chemical synthesis routes.

1. Fmoc Solid-Phase Peptide Synthesis

N-α-Fmoc-L-glutamine is used in peptide synthesis workflows where Fmoc-based N-protection enables stepwise assembly on solid supports. The Fmoc carbamate masks the α-amino group for controlled peptide coupling, while the L-glutamine side-chain amide remains available for hydrogen-bonding interactions in the growing sequence. The free carboxylic acid can be activated using standard peptide coupling chemistries to form amide bonds with incoming amino acid building blocks, supporting incorporation of glutamine residues into peptides and peptidomimetics. The resulting glutamine-containing peptides can be used as biochemical research reagents, reference standards, and scaffold components for structure-activity relationship studies, with the protected amino acid chemistry remaining compatible with common deprotection and coupling cycles.

2. Side-Chain Amide Derivatization

N-α-Fmoc-L-glutamine is applied in amino acid modification strategies that exploit the glutamine side-chain amide for controlled functional transformation. The preserved side-chain carbonyl and terminal amide nitrogen enable conversion routes such as acylation, selective activation for conjugation chemistry, or orthogonal protection patterns that can be introduced after peptide assembly. The Fmoc-protected α-amino group provides a handle for sequential synthesis while keeping the side-chain functionality intact during intermediate preparation. Downstream derivatization can generate labeled glutamine analogs, affinity tags, or chemically reactive glutamine-containing intermediates used in chemical biology and peptide-based molecular design, supporting generation of functional molecules with defined polar recognition motifs.

3. Unnatural Amino Acid Incorporation

N-α-Fmoc-L-glutamine serves as a chiral precursor for routes that require glutamine-like functionality in unnatural amino acid incorporation and peptidomimetic construction. The L-stereocenter and protected α-amino group allow the molecule to be processed as a defined stereochemical unit, while the side-chain amide can be retained or transformed to access glutamine mimics with altered hydrogen-bonding patterns. Fmoc protection supports compatibility with automated peptide synthesis platforms, enabling incorporation of glutamine residues into analog libraries where subsequent side-chain modification tunes polarity and conformational preferences. The resulting glutamine-derived building blocks and peptide analogs can be employed for SAR studies, molecular recognition mapping, and mechanistic investigations in applied peptide science.

4. Bioconjugation Linker Chemistry

N-α-Fmoc-L-glutamine is utilized in bioconjugation workflows where glutamine's side-chain amide can serve as a functional anchor for conjugate construction. The molecule's protected α-amino group supports controlled handling during synthesis of peptide linkers that later undergo deprotection to expose reactive amine sites for coupling to biomolecules. The side-chain amide can participate in amide-forming transformations or be used as a polar spacer element that improves solubility and reduces nonspecific aggregation in conjugates. Glutamine-containing linker peptides and conjugation-ready intermediates can be applied in biochemical research reagent preparation, biomolecule labeling, and the generation of defined molecular probes for studying binding and processing events.

5. Pharmaceutical Intermediate Synthesis

N-α-Fmoc-L-glutamine is relevant to pharmaceutical intermediate preparation and specialty chemical production where protected amino acids are manufactured as controlled building blocks for peptide-active or peptide-adjacent compounds. The Fmoc group provides a stable N-protection strategy that can be removed under base in downstream processing, supporting manufacturing routes that require predictable deprotection behavior and minimized side reactions. The presence of a single stereocenter and a functional side-chain amide supports consistent batch-to-batch structure for downstream coupling steps, including formation of peptide bonds and controlled derivatization of glutamine residues. The compound can be employed as a process chemistry intermediate for producing glutamine-containing peptide fragments, reference materials, and synthetic intermediates used in industrial fine chemical synthesis and applied peptide manufacturing.

6. Analytical Reference Standards

N-α-Fmoc-L-glutamine is suitable for analytical research and method development requiring a defined, protected glutamine standard with a known stereochemical identity. The Fmoc-protected carbamate and the intact side-chain amide produce characteristic chromatographic and spectroscopic signatures that can support LC-MS, HPLC, and NMR characterization of peptide synthesis intermediates and deprotection outcomes. The molecule's structural definition enables use as a calibration or qualification reference when monitoring incorporation of glutamine residues in peptide building block preparations. Glutamine-containing analytical standards derived from N-α-Fmoc-L-glutamine can further support quality control of peptide coupling chemistry, intermediate purity tracking, and structural verification during applied biochemical research and industrial chemical manufacturing.

1. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency